vimarsana.com

Page 93 - Dexcom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DexCom (NASDAQ:DXCM) Given Outperform Rating at Leerink Partnrs

Leerink Partnrs restated their outperform rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research note issued to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for DexCom’s Q3 2023 earnings at $0.37 EPS, Q4 2023 earnings at $0.42 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.39 […]

Does DexCom (DXCM) Have an Attractive Long-Term Runway for Growth?

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund declined 6.05% (Institutional Shares) in the quarter compared to a 3.88% loss for the Russell 3000 Health Care Index and a 3.27% loss for the S&P 500 Index. […]

Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday - Abbott Laboratories (NYSE:ABT), Ardelyx (NASDAQ:ARDX)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.